Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carlos Luri‐Rey
Observed names:
C. Luri-Rey,
Carlos Luri,
Carlos Luri-Rey,
Luri-Rey, Carlos,
carlos luri-Rey
Institutions:
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Centro de Investigación Biomédica en Red de Cáncer,
Centro de Investigación Médica Aplicada
Observed institutions:
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Centro de Investigación Biomédica en Red de Cáncer,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
ORCID:
0000-0001-6476-0998
Observed ORCID:
0000-0001-6476-0998
OpenAlex ID:
A5033928193
Cross-priming in cancer immunology and immunotherapy
2025
·
Carlos Luri-Rey
, Álvaro Teijeira
, et al.
·
Nature reviews. Cancer
·
162
Novel strategies exploiting interleukin-12 in cancer immunotherapy
2022
·
Assunta Cirella
, Carlos Luri-Rey
, et al.
·
Pharmacology & Therapeutics
·
108
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary
2022
·
Ignacio Melero
, Miguel F. Sanmamed
, et al.
·
Cancer Discovery
·
90
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers
2022
·
Alvaro Teijeira
, Itziar Migueliz
, et al.
·
Theranostics
·
73
PDF
mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
2023
·
Irene Olivera
, Elixabet Bolaños
, et al.
·
Cell Reports Medicine
·
55
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
2022
·
Alvaro Teijeira
, Saray Garasa
, et al.
·
Cancer Research
·
41
PDF
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps
2024
·
Alvaro Teijeira
, Saray Garasa
, et al.
·
Clinical Cancer Research
·
33
Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
2023
·
Ignacio Melero
, Maria C Ochoa
, et al.
·
EMBO Molecular Medicine
·
28
PDF
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
2022
·
Javier Glez-Vaz
, Arantza Azpilikueta
, et al.
·
Journal for ImmunoTherapy of Cancer
·
28
PDF
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity
2022
·
Assunta Cirella
, Elixabet Bolaños
, et al.
·
Cancer Immunology Research
·
26
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma
2023
·
Maria Carmen Ochoa
, Sandra Sanchez-Gregorio
, et al.
·
Cell Reports Medicine
·
25
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming
2023
·
Carlos Luri‐Rey
, Gabriel Gomis
, et al.
·
Immunological Reviews
·
24
Immunocytokines and cytokine neutralization for cancer immunotherapy
2025
·
Pedro Berraondo
, Raquel Cuesta
, et al.
·
Trends in cancer
·
23
Interleukin-18 in cancer immunology and immunotherapy
2023
·
Assunta Cirella
, Irene Olivera
, et al.
·
Expert Opinion on Therapeutic Targets
·
23
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
2025
·
Eneko Garate-Soraluze
, Irantzu Serrano-Mendioroz
, et al.
·
Journal for ImmunoTherapy of Cancer
·
19
PDF
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
2023
·
Maite Alvarez
, Carmen Molina
, et al.
·
OncoImmunology
·
17
Regional and intratumoral adoptive T-cell therapy
2024
·
I. Olivera
, I. Etxeberria
, et al.
·
Immuno-Oncology Technology
·
15
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects
2023
·
Javier Glez-Vaz
, Arantza Azpilikueta
, et al.
·
Science Advances
·
12
PDF
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists
2023
·
Assunta Cirella
, Elixabet Bolaños
, et al.
·
Molecular Therapy — Nucleic Acids
·
10
Dendritic cells, headhunters for anti-tumor CD8+ T cells in triple-negative breast cancer
2023
·
Carlos Luri-Rey
, Almudena Manzanal
, et al.
·
Med
·
7
Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer
2026
·
Alvaro Lopez-Janeiro
, José González-Gomariz
, et al.
·
Journal of Clinical Investigation
·
5
PDF
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
2023
·
Irene Olivera
, Carlos Luri-Rey
, et al.
·
Clinical Cancer Research
·
5
Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations
2026
·
Gabriel Gomis
, Pedro Berraondo
, et al.
·
Trends in Immunology
·
2
Antigen-presenting mast cells are new players in breast cancer immunotherapy
2025
·
Carlos Luri-Rey
, Álvaro Teijeira
, et al.
·
Nature Medicine
·
2
Druggable Targets in Cytokine Release Syndromes
2023
·
Carlos Luri-Rey
, Iñaki Eguren-Santamaria
, et al.
·
Clinical Cancer Research
·
2
Show more works
View as search
Works count:
73
Citation count:
839
H-index:
16
I10-index:
19
Year
Topic
Type